← Back to Search

Telemedicine Visit for Kidney Failure

N/A
Waitlist Available
Led By Aditya Mattoo, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.

Eligible Conditions
  • Kidney Failure
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cost
Missed visits
Waiting time

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine VisitExperimental Treatment1 Intervention
Group II: Usual Care VisitActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telemedicine Visit
2017
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,494 Total Patients Enrolled
Aditya Mattoo, MDPrincipal InvestigatorNYU Langone Health
Nicole Ali, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025